metsera glp-1 Weight-loss newbie says once-monthly amylin matches efficacy The weight-loss-independent hepatoprotective benefits of

In contrast to pioglitazone, saroglitazar does not seem to correlate with weight gain and peripheral edema [66]

Now, the drop in body fat was only about 2 pounds over 12 weeks, and the drop in abdominal fat in the higher dose group was almost totally a drop in subcutaneous fat, the flabby superficial fatnot the dangerous visceral fat deeper down that really matters for health

But more serious rare risks are also possible, including pancreatitis and stomach or gallbladder problems

Metformin is a separate class of diabetes drug that lowers blood sugar by reducing liver glucose production and improving insulin sensitivity